Search - Archive ouverte HAL Access content directly

Filter your results

3 Results
Structure: Internal structure identifier : 519452
Image document

Dasatinib in high-risk core binding factor acute myeloid leukemia in first complete remission: a French Acute Myeloid Leukemia Intergroup trial

Nicolas Boissel , Aline Renneville , Thibaut Leguay , Pascale Cornillet Lefebvre , Christian Recher et al.
Haematologica, 2015, 100 (6), pp.780 - 785. ⟨10.3324/haematol.2014.114884⟩
Journal articles inserm-01820455v1

Core-binding factor acute myeloid leukemia in first relapse: a retrospective study from the French AML Intergroup

A. Hospital , T. Prebet , S. Bertoli , X. Thomas , E. Tavernier et al.
Blood, 2014, 124 (8), pp.1312 - 1319. ⟨10.1182/blood-2014-01-549212⟩
Journal articles hal-01688071v1

Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial

Anne Bouvier , Jean-Francois Hamel , Jacques Delaunay , Eric Delabesse , Pierre-Yves Dumas et al.
European Journal of Haematology, 2021, 107 (1), pp.111-121. ⟨10.1111/ejh.13626⟩
Journal articles hal-03604930v1